Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection

Gastroenterology. 2018 Feb;154(3):652-662.e8. doi: 10.1053/j.gastro.2017.10.017. Epub 2017 Oct 24.

Abstract

Background & aims: NVR3-778 is a capsid assembly modulator in clinical development. We determined the in vivo antiviral efficacy and effects on innate and endoplasmic reticulum (ER) stress responses of NVR3-778 alone or in combination with pegylated interferon alpha (peg-IFN) and compared with entecavir.

Methods: We performed 2 studies, with a total of 61 uPA/SCID mice with humanized livers. Mice were infected with a hepatitis B virus (HBV) genotype C preparation; we waited 8 weeks for persistent infection of the human hepatocytes in livers of mice. Mice were then randomly assigned to groups (5 or 6 per group) given vehicle (control), NVR3-778, entecavir, peg-IFN, NVR3-778 + entecavir, or NVR3-778 + peg-IFN for 6 weeks. We measured levels of HB surface antigen, HB e antigen, HBV RNA, alanine aminotransferase, and human serum albumin at different time points. Livers were collected and analyzed by immunohistochemistry; levels of HBV DNA, covalently closed circular DNA, and HBV RNA, along with markers of ER stress and IFN response, were quantified.

Results: Mice given NVR3-778 or entecavir alone for 6 weeks had reduced serum levels of HBV DNA compared with controls or mice given peg-IFN. The largest reduction was observed in mice given NVR3-778 + peg-IFN; in all mice in this group, the serum level of HBV DNA was below the limit of quantification. NVR3-778 and peg-IFN, but not entecavir, also reduced serum level of HBV RNA. The largest effect was obtained in the NVR3-778 + peg-IFN group, in which serum level of HBV RNA was below the limit of quantification. Levels of HB surface antigen and HB e antigen were reduced significantly in only the groups that received peg-IFN. Levels of covalently closed circular DNA did not differ significantly among groups. NVR3-778 was not associated with any significant changes in level of alanine aminotransferase, the ER stress response, or IFN-stimulated genes.

Conclusions: NVR3-778 has high antiviral activity in mice with humanized livers and stable HBV infection, reducing levels of serum HBV DNA and HBV RNA. Entecavir reduced levels of serum HBV DNA, but had no effect on HBV RNA. The combination of NVR3-778 and peg-IFN prevented viral replication and HBV RNA particle production to a greater extent than each compound alone or entecavir.

Keywords: Assembly Inhibitor Core Protein; CAM; DAA; ER Stress Response; Replication.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Antiviral Agents / pharmacology*
  • DNA, Viral / genetics
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Endoplasmic Reticulum Stress / drug effects
  • Genotype
  • Guanine / analogs & derivatives*
  • Guanine / pharmacology
  • Hepatitis B / diagnosis
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / genetics
  • Hepatitis B virus / growth & development
  • Hepatocytes / drug effects*
  • Hepatocytes / transplantation
  • Hepatocytes / virology
  • Humans
  • Interferon Regulatory Factors / genetics
  • Interferon Regulatory Factors / metabolism
  • Interferon-alpha / pharmacology*
  • Mice, SCID
  • Mice, Transgenic
  • Phenotype
  • Polyethylene Glycols / pharmacology*
  • RNA, Viral / genetics
  • Recombinant Proteins / pharmacology
  • Serum Albumin, Human / metabolism
  • Time Factors
  • Urokinase-Type Plasminogen Activator / genetics*
  • Viral Load

Substances

  • ALB protein, human
  • Antiviral Agents
  • DNA, Viral
  • Hepatitis B e Antigens
  • Interferon Regulatory Factors
  • Interferon-alpha
  • RNA, Viral
  • Recombinant Proteins
  • Polyethylene Glycols
  • entecavir
  • Guanine
  • Alanine Transaminase
  • Urokinase-Type Plasminogen Activator
  • peginterferon alfa-2a
  • Serum Albumin, Human